SCHEMBL8059786

SCHEMBL8059786

CCCCOC(=O)N1CCCC(O)C1c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.46
CHRM4 P08173 1/20 0.46
CHRM5 P08912 1/20 0.46
CHRM1 P11229 1/20 0.46
CHRM3 P20309 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.44
ACE P12821 2/20 0.42
ACE2 Q9BYF1 2/20 0.42
PRCP P42785 1/20 0.41
BCHE P06276 1/20 0.41
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41
HCRTR2 O43614 1/20 0.40
FKBP1A P62942 3/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
KMT2A Q03164 1/20 0.40
RIPK1 Q13546 1/20 0.40
TSHR P16473 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9274408 1.00 CHRM2 (0.46) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL8318035 0.88 KMT2A (0.50) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL6668590 0.87 CHRM2 (0.45) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9200215 0.82 RAB9A (0.55) ACE2PRMT5WDR77HCRTR2RIPK1
SCHEMBL8157683 0.81 PREP (0.53) L3MBTL1ACE2KMT2ATSHR
SCHEMBL29540420 0.81 TMEM97 (0.56) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL22721972 0.81 TMEM97 (0.56) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9025393 0.78 TACR1 (0.55) PRCPKDM4ELMNA
SCHEMBL9270977 0.78 TACR1 (0.38) HCRTR2RIPK1
SCHEMBL8125588 0.78 RIPK1 (0.52) L3MBTL1HCRTR2MEN1KMT2ARIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001780-A1 USE OF NK-1 RECEPTOR ANTAGONISTS FOR TREATING MANIA MERCK SHARP & DOHME LTD. (GB) 2000-05-24 EP disclosed
EP-0929554-A1 SPIRO-AZACYCLIC DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS MERCK SHARP & DOHME LTD. (GB) 1999-07-21 EP disclosed
WO-1999007374-A1 USE OF NK-1 RECEPTOR ANTAGONISTS FOR TREATING AGGRESSIVE BEHAVIOUR MERCK SHARP & DOHME LIMITED (GB) 1999-02-18 WO disclosed
WO-1999007376-A1 USE OF NK-1 RECEPTOR ANTAGONISTS FOR TREATING MANIA MERCK SHARP & DOHME LIMITED (GB) 1999-02-18 WO disclosed
EP-0835253-A1 PIPERIDINE AND MORPHOLINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME LTD. (GB) 1998-04-15 EP disclosed
WO-1998013369-A1 SPIRO-AZACYCLIC DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS MERCK SHARP & DOHME LIMITED (GB) 1998-04-02 WO disclosed
EP-0652866-A1 AZACYCLIC COMPOUNDS MERCK SHARP & DOHME LTD. (GB) 1995-05-17 EP disclosed
EP-0636130-A1 AZACYCLIC COMPOUNDS MERCK SHARP & DOHME LTD. (GB) 1995-02-01 EP disclosed
EP-0600952-A1 AZACYCLIC COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. MERCK SHARP & DOHME (GB) 1994-06-15 EP disclosed
WO-1993004040-A1 AZACYCLIC COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM MERCK SHARP & DOHME LIMITED (GB) 1993-03-04 WO disclosed